Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis

Background: Neuropsychiatric symptoms (NPS) are common in individuals with Alzheimer’s disease (AD) dementia, but substantial heterogeneity exists in the manifestation of NPS. Sex differences may explain this clinical variability. We aimed to investigate the sex differences in the prevalence and sev...

Full description

Bibliographic Details
Main Authors: Coesmans, M. (Author), Eikelboom, W.S (Author), Fischer, C.E (Author), Gatchel, J.R (Author), Ismail, Z. (Author), Lanctôt, K.L (Author), Mortby, M.E (Author), Ossenkoppele, R. (Author), Pan, M. (Author), Papma, J.M (Author), van den Berg, E. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Sex
Online Access:View Fulltext in Publisher
LEADER 03688nam a2200325Ia 4500
001 10-1186-s13195-022-00991-z
008 220420s2022 CNT 000 0 und d
020 |a 17589193 (ISSN) 
245 1 0 |a Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis 
260 0 |b BioMed Central Ltd  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1186/s13195-022-00991-z 
520 3 |a Background: Neuropsychiatric symptoms (NPS) are common in individuals with Alzheimer’s disease (AD) dementia, but substantial heterogeneity exists in the manifestation of NPS. Sex differences may explain this clinical variability. We aimed to investigate the sex differences in the prevalence and severity of NPS in AD dementia. Methods: Literature searches were conducted in Embase, MEDLINE/PubMed, Web of Science Core Collection, Cochrane Central Register of Controlled Trials, PsycINFO, and Google Scholar from inception to February 2021. Study selection, data extraction, and quality assessment were conducted in duplicate. Effect sizes were calculated as odds ratios (OR) for NPS prevalence and Hedges’ g for NPS severity. Data were pooled using random-effects models. Sources of heterogeneity were examined using meta-regression analyses. Results: Sixty-two studies were eligible representing 21,554 patients (61.2% females). The majority of the included studies had an overall rating of fair quality (71.0%), with ten studies of good quality (16.1%) and eight studies of poor quality (12.9%). There was no sex difference in the presence of any NPS (k = 4, OR = 1.35 [95% confidence interval 0.78, 2.35]) and overall NPS severity (k = 13, g = 0.04 [− 0.04, 0.12]). Regarding specific symptoms, female sex was associated with more prevalent depressive symptoms (k = 20, OR = 1.60 [1.28, 1.98]), psychotic symptoms (general psychosis k = 4, OR = 1.62 [1.12, 2.33]; delusions k = 12, OR = 1.56 [1.28, 1.89]), and aberrant motor behavior (k = 6, OR = 1.47 [1.09, 1.98]). In addition, female sex was related to more severe depressive symptoms (k = 16, g = 0.24 [0.14, 0.34]), delusions (k = 10, g = 0.19 [0.04, 0.34]), and aberrant motor behavior (k = 9, g = 0.17 [0.08, 0.26]), while apathy was more severe among males compared to females (k = 11, g = − 0.10 [− 0.18, − 0.01]). There was no association between sex and the prevalence and severity of agitation, anxiety, disinhibition, eating behavior, euphoria, hallucinations, irritability, and sleep disturbances. Meta-regression analyses revealed no consistent association between the effect sizes across studies and method of NPS assessment and demographic and clinical characteristics. Discussion: Female sex was associated with a higher prevalence and greater severity of several specific NPS, while male sex was associated with more severe apathy. While more research is needed into factors underlying these sex differences, our findings may guide tailored treatment approaches of NPS in AD dementia. © 2022, The Author(s). 
650 0 4 |a Alzheimer’s disease 
650 0 4 |a Behavioral and psychological symptoms of dementia 
650 0 4 |a Behavioral symptoms 
650 0 4 |a Meta-analysis 
650 0 4 |a Neuropsychiatry 
650 0 4 |a Sex 
700 1 0 |a Coesmans, M.  |e author 
700 1 0 |a Eikelboom, W.S.  |e author 
700 1 0 |a Fischer, C.E.  |e author 
700 1 0 |a Gatchel, J.R.  |e author 
700 1 0 |a Ismail, Z.  |e author 
700 1 0 |a Lanctôt, K.L.  |e author 
700 1 0 |a Mortby, M.E.  |e author 
700 1 0 |a Ossenkoppele, R.  |e author 
700 1 0 |a Pan, M.  |e author 
700 1 0 |a Papma, J.M.  |e author 
700 1 0 |a van den Berg, E.  |e author 
773 |t Alzheimer's Research and Therapy